Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

40.0%

2 terminated/withdrawn out of 5 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01729533Not ApplicableWithdrawn

The Benefits of Intracytoplasmic Morphologically Selected Sperm Injection (IMSI) in Couples With Unexplained Infertility

Role: lead

NCT01727947Not ApplicableCompleted

Influence of Sperm With Large Nuclear Vacuole on ICSI Outcomes

Role: lead

NCT02107521Not ApplicableTerminated

IMSI in Couples With Previous Implantation Failures

Role: lead

NCT01731639Not ApplicableCompleted

Motile Sperm Organelle Morphology Examination (MSOME) Influence on Intracytoplasmic Sperm Injection (ICSI) Outcomes in Infertile Couples

Role: lead

NCT01620346Not ApplicableCompleted

Intracytoplasmic Morphologically Selected Sperm Injection and Advanced Maternal Age

Role: lead

All 5 trials loaded